Cost analysis of radiofrequency catheter ablation for atrial fibrillation

Gorenek B., Kudaiberdieva G.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.167, no.6, pp.2462-2467, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 167 Issue: 6
  • Publication Date: 2013
  • Doi Number: 10.1016/j.ijcard.2013.01.028
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2462-2467
  • Eskisehir Osmangazi University Affiliated: Yes


Atrial fibrillation is the most common arrhythmia associated with increased mortality and morbidity. Its management requires high healthcare expenditures; 52%-70% of expenses for AF care are constituted by hospitalization costs. The current management strategies of pharmacological rhythm control and pharmacological or invasive rate control show no difference in impact on major outcomes in patients with AF. Radiofrequency catheter ablation (RFA) has been shown to reduce the risk of AF recurrence, improve quality of life and reduce hospitalization rate as compared to pharmacological rhythm control and rate control strategies. This review summarizes current knowledge on cost and cost-effectiveness analysis of RFA for patients with atrial fibrillation. (C) 2013 Elsevier Ireland Ltd. All rights reserved.